- Home
- REPL vs FRPH Comparison
REPL vs FRPH Comparison
Compare REPL & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- FRPH
- Stock Information
- Founded
- REPL 2015
- FRPH 1986
- Country
- REPL United States
- FRPH United States
- Employees
- REPL N/A
- FRPH N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- FRPH Real Estate
- Sector
- REPL Health Care
- FRPH Finance
- Exchange
- REPL Nasdaq
- FRPH Nasdaq
- Market Cap
- REPL 547.0M
- FRPH 459.4M
- IPO Year
- REPL 2018
- FRPH N/A
- Fundamental
- Price
- REPL $10.07
- FRPH $23.32
- Analyst Decision
- REPL Buy
- FRPH
- Analyst Count
- REPL 9
- FRPH 0
- Target Price
- REPL $10.88
- FRPH N/A
- AVG Volume (30 Days)
- REPL 8.8M
- FRPH 54.6K
- Earning Date
- REPL 11-07-2025
- FRPH 11-05-2025
- Dividend Yield
- REPL N/A
- FRPH N/A
- EPS Growth
- REPL N/A
- FRPH N/A
- EPS
- REPL N/A
- FRPH 0.28
- Revenue
- REPL N/A
- FRPH $32,293,999.00
- Revenue This Year
- REPL N/A
- FRPH N/A
- Revenue Next Year
- REPL N/A
- FRPH N/A
- P/E Ratio
- REPL N/A
- FRPH $82.69
- Revenue Growth
- REPL N/A
- FRPH 3.18
- 52 Week Low
- REPL $2.68
- FRPH $22.95
- 52 Week High
- REPL $17.00
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- REPL 75.32
- FRPH 35.22
- Support Level
- REPL $7.69
- FRPH $22.95
- Resistance Level
- REPL $10.85
- FRPH $24.80
- Average True Range (ATR)
- REPL 0.67
- FRPH 0.62
- MACD
- REPL 0.48
- FRPH -0.14
- Stochastic Oscillator
- REPL 88.10
- FRPH 14.23
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).